Rock Springs Capital Management LP 13D and 13G filings for Agios Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-02-14 2:06 pm Sale | 2023-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | Rock Springs Capital Management LP | 2,152,173 3.850% | -844,419![]() (-28.18%) | Filing |
2023-02-14 2:50 pm Purchase | 2022-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | Rock Springs Capital Management LP | 2,996,592 5.450% | 2,996,592![]() (New Position) | Filing |